Renaissance Technologies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-361,400
| Closed | -$14.8M | – | 4002 |
|
|
2024
Q2 | $14.8M | Sell |
361,400
-88,000
| -20% | -$3.6M | 0.03% | 732 |
|
|
2024
Q1 | $19M | Buy |
449,400
+209,900
| +88% | +$8.87M | 0.03% | 662 |
|
|
2023
Q4 | $10.2M | Buy |
+239,500
| New | +$10.2M | 0.02% | 943 |
|
|
2022
Q2 | – | Sell |
-9,900
| Closed | -$347K | – | 4648 |
|
|
2022
Q1 | $347K | Buy |
+9,900
| New | +$347K | ﹤0.01% | 3403 |
|
|
2021
Q3 | – | Sell |
-56,200
| Closed | -$1.44M | – | 3939 |
|
|
2021
Q2 | $1.44M | Buy |
+56,200
| New | +$1.44M | ﹤0.01% | 2466 |
|